The Speech Accessibility Project has begun recruiting U.S. and Puerto Rican adults who have had a stroke.
CellCentric receives FDA Fast Track designation for relapsed refractory multiple myeloma drug
CellCentric has announced that the U.S. Food and Drug Administration (FDA) has granted its novel cancer drug, inobrodib, Fast Track designation for the treatment of